Freeline Therapeutics Holdings plc Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Freeline Therapeutics Holdings plc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2023 was -$472M, a 11.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 -$472M -$49.9M -11.8% Sep 30, 2023 6-K 2023-12-01
Q2 2023 -$460M -$52.7M -12.9% Jun 30, 2023 6-K 2023-08-15
Q1 2023 -$444M -$61.1M -15.9% Mar 31, 2023 6-K 2023-05-30
Q4 2022 -$445M -$89M -25% Dec 31, 2022 6-K 2023-12-01
Q3 2022 -$422M -$101M -31.3% Sep 30, 2022 6-K 2022-11-15
Q2 2022 -$407M -$117M -40.1% Jun 30, 2022 6-K 2022-08-09
Q1 2022 -$383M -$132M -52.7% Mar 31, 2022 6-K 2022-05-10
Q4 2021 -$356M -$140M -65% Dec 31, 2021 20-F 2023-04-04
Q3 2021 -$322M Sep 30, 2021 6-K 2021-11-09
Q2 2021 -$291M -$138M -90.2% Jun 30, 2021 6-K 2021-08-16
Q1 2021 -$251M Mar 31, 2021 6-K 2021-05-17
Q4 2020 -$216M -$96.3M -80.5% Dec 31, 2020 20-F 2022-03-31
Q2 2020 -$153M Jun 30, 2020 6-K 2020-10-29
Q4 2019 -$120M Dec 31, 2019 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.